Clinical Trials Directory

Trials / Conditions / AD

AD

15 registered clinical trials studyying AD — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study to Evaluate the Efficacy and Safety of TTYP01 Tablets in Early Symptomatic Alzheimer's Disease
NCT07252440
Shanghai Auzone Biological Technology Co., Ltd.Phase 2
Not Yet RecruitingMetabolic Characterization of Alzheimer's Disease and Frontotemporal Dementia by 23Na-MRI and FDG-PET
NCT07100470
Centre Hospitalier St AnneN/A
Active Not RecruitingATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis
NCT07011706
Aclaris Therapeutics, Inc.Phase 2
RecruitingThe Effects of Social Isolation and Social Interaction on the Risk of Dementia Progression and Brain Function
NCT06335836
The First Affiliated Hospital with Nanjing Medical University—
Enrolling By InvitationExtension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
NCT06245031
Cognito Therapeutics, Inc.N/A
CompletedA Phase I Clinical Study on the Safety and Pharmacokinetics of [18F]Florbetazine Injection
NCT06593626
HTA Co., Ltd.Phase 1
TerminatedA Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD
NCT05984784
Inmagene LLCPhase 1 / Phase 2
UnknownDevelopment and Application of Intelligent Diagnosis and Treatment Norms for Children and Adolescents With Men
NCT06155201
Chen LiN/A
UnknownThe Mechanism Study of Diabetic Pancreatic Amyloid Deposition on Cognitive Dysfunction in Alzheimer's Disease
NCT05372458
Huashan Hospital—
UnknownAn Open-label, Single-arm Longitudinal Study With Dupilumab for Patients With Atopic Dermatitis
NCT04520308
Eric SimpsonPhase 4
CompletedSafety and Pharmacokinetic of Donepezil Pamoate in Healthy Subjects
NCT03932916
Shanghai Synergy Pharmaceutical Sciences Co., Ltd.Phase 1
CompletedEffects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease
NCT02380573
The University of Texas Health Science Center at San AntonioPhase 2
TerminatedA Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807
NCT01733355
Avid RadiopharmaceuticalsEARLY_Phase 1
CompletedHormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
NCT01190904
Icahn School of Medicine at Mount Sinai—
CompletedThe Use of EEG in Alzheimer's Disease, With and Without Scopolamine - A Pilot Study
NCT02273895
Mentis CuraN/A